In a previous study, we proposed that the S100A9-TLR4 interaction may promote tumor growth [31], and as discussed therein and in more recent publications from our group [33, 34], one mode of action of tasquinimod may be to interfere with that interaction. This evidence concerns the gene TLR4 and neoplasm.